ChemicalBook--->CAS DataBase List--->1445656-91-6

1445656-91-6

1445656-91-6 Structure

1445656-91-6 Structure
IdentificationBack Directory
[Name]

Cyclopropanecarboxylic acid, 1-[5-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-8-methoxy[1,2,4]triazolo[1,5-a]pyridin-2-yl]-, 2-methylpropyl ester
[CAS]

1445656-91-6
[Synonyms]

LEO 39652
isobutyl 1-(8-methoxy-5-(1-oxo-1,3-dihydroisobenzofuran-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropane-1-carboxylate
Cyclopropanecarboxylic acid, 1-[5-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-8-methoxy[1,2,4]triazolo[1,5-a]pyridin-2-yl]-, 2-methylpropyl ester
[Molecular Formula]

C23H23N3O5
[MDL Number]

MFCD33023450
[MOL File]

1445656-91-6.mol
[Molecular Weight]

421.45
Chemical PropertiesBack Directory
[storage temp. ]

Store at -20°C
[solubility ]

DMSO : 25 mg/mL (59.32 mM; Need ultrasonic)
[form ]

Solid
[color ]

Off-white to gray
Hazard InformationBack Directory
[Biological Activity]

LEO 39652 is a dual-soft PDE4 inhibitor with IC50s of 1.2 nM, 1.2 nM, 3.0 nM and 3.8 nM for PDE4A, PDE4B, PDE4C and PDE4D, respectively. LEO 39652 also inhibits TNF-α with an IC50 value of 6.0 nM. LEO 39652 is used for topical research of Atopic dermatitis (AD) [1]. LEO 39652 shows unbound in vitro potency when measured as LPS induced TNF-α release in human peripheral blood mononuclear cells (PBMC), incubated in serum free medium. LEO 39652 shows a relatively high binding to human serum albumin[2]. LEO 39652 is inactivated both in blood and liver (dual-soft) while stabled in the skin[1].Pharmacokinetic AnalysisLEO 39652 exhibits total clearance (rats 930, minipigs 200 and monkey 300 mL/min/kg) and ratio to total AUC (rats 4, minipigs 6 and monkey 6 %) following intravenous administration (rats 0.075, minipigs 0.5 and monkeys 2.0 mg/kg)[1].
[References]

[1]. Jens Larsen, et al. Discovery and Early Clinical Development of Isobutyl 1-[8-Methoxy-5-(1-oxo-3 H-isobenzofuran-5-yl)-[1,2,4]triazolo[1,5- a]pyridin-2-yl]cyclopropanecarboxylate (LEO 39652), a Novel "Dual-Soft" PDE4 Inhibitor for Topical Treatment of Atopic Dermatitis. J Med Chem. 2020 Dec 10;63(23):14502-14521. [2]. Stefan Eirefelt, et al. Evaluating Dermal Pharmacokinetics and Pharmacodymanic Effect of Soft Topical PDE4 Inhibitors: Open Flow Microperfusion and Skin Biopsies. Pharm Res. 2020 Nov 13;37(12):243.
1445656-91-6 suppliers list
Company Name: CONIER CHEM AND PHARMA LIMITED
Tel: +8618523575427 , +8618523575427
Website: http://www.conier.com/
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Website: www.aladdinsci.com/
Company Name: Yujinpharma(Tianjin) Technology Co.,Ltd.  
Tel: 13370351217 kungfu1217@1
Website: http://www.yujinpharma.com
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Website: https://www.chemicalbook.com/ShowSupplierProductsList927327/0.htm
Company Name: Birdo (Shanghai) Medical Technology Co., Ltd.  
Tel: 021-021-021-58099077-8102-8041-8041 18601625411
Website: https://product.birdotech.com/
Company Name: Taizhou Nanfeng Pharmaceutical Research Institute  
Tel: 18616377689
Website: www.chemicalbook.com/showsupplierproductslist1580880/0.htm
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Website: https://www.targetmol.cn/
Company Name: Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.  
Tel: 13771642864
Website: https://www.chemicalbook.com/ShowSupplierProductsList1659441/0.htm
Company Name: RD International Technology Co., Limited  
Tel: 18024082417
Website: www.ruidiresearch.com
Tags:1445656-91-6 Related Product Information